|
Market Closed -
Toronto S.E.
10:05:55 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0750 CAD | 0.00% |
|
0.00% | -16.67% |
Company Valuation: Hemostemix Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 32.46 | 9.464 | 13.63 | 6.099 | 17 | 17.57 |
| Change | - | -70.84% | 44.06% | -55.27% | 178.71% | 3.39% |
| Enterprise Value (EV) 1 | 32.38 | 10.73 | 17.62 | 10.26 | 21.23 | 20.43 |
| Change | - | -66.87% | 64.3% | -41.76% | 106.81% | -3.74% |
| P/E | -2.91x | -1.46x | -2.41x | -2.31x | -4.36x | -3.12x |
| PBR | -35.4x | -1.79x | -2.01x | -0.83x | -2.34x | -3.53x |
| PEG | - | 0x | 0.1x | 0x | 0.47x | -0.65x |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -6.64x | -1.61x | -5.38x | -4.4x | -11.1x | -3.88x |
| EV / EBIT | -6.64x | -1.61x | -5.38x | -4.4x | -11.1x | -3.88x |
| EV / FCF | -20x | -10.5x | -4.62x | -8.35x | -14.3x | -6.18x |
| FCF Yield | -5.01% | -9.48% | -21.7% | -12% | -6.97% | -16.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.241 | -0.1094 | -0.0748 | -0.0303 | -0.0275 | -0.0288 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | - | - |
| EBITDA 1 | -4.876 | -6.655 | -3.273 | -2.333 | -1.912 | -5.266 |
| EBIT 1 | -4.879 | -6.656 | -3.274 | -2.334 | -1.912 | -5.266 |
| Net income 1 | -7.768 | -6.286 | -5.235 | -2.502 | -2.616 | -4.714 |
| Net Debt 1 | -0.083 | 1.262 | 3.99 | 4.166 | 4.231 | 2.861 |
| Reference price 2 | 0.7000 | 0.1600 | 0.1800 | 0.0700 | 0.1200 | 0.0900 |
| Nbr of stocks (in thousands) | 46,369 | 59,151 | 75,743 | 87,122 | 141,642 | 195,253 |
| Announcement Date | 4/30/21 | 5/3/22 | 5/1/23 | 4/29/24 | 4/29/25 | 5/1/26 |
1CAD in Million2CAD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 10.76M | |
| 20.62x | 7.16x | 14.45x | 1.43% | 69.02B | |
| 37.68x | 9.86x | 30.11x | 0.04% | 66.32B | |
| -77.54x | 14.97x | -72.18x | -.--% | 27.66B | |
| -15.71x | 6.02x | -7.56x | -.--% | 25.84B | |
| 30.64x | 6.56x | 17.04x | -.--% | 26.54B | |
| 27.79x | 5.19x | 17.27x | -.--% | 20.4B | |
| 50.92x | 18.81x | 38.16x | 0.3% | 17.63B | |
| 1308.71x | 37.87x | 826.39x | -.--% | 15.15B | |
| 18.26x | 5.45x | 12.72x | -.--% | 14.65B | |
| Average | 155.71x | 12.43x | 97.38x | 0.2% | 28.32B | |
| Weighted average by Cap. | 83.82x | 10.53x | 52.90x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- HEM Stock
- Valuation Hemostemix Inc.
Select your edition
All financial news and data tailored to specific country editions
